Cargando…
Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
Alpha-synuclein (αSyn) is encoded by the first causal gene identified in Parkinson's disease (PD) and is the main component of Lewy bodies, a pathological hallmark of PD. aSyn-based animal models have contributed to our understanding of PD pathophysiology and to the development of therapeutics....
Autores principales: | Cai, Waijiao, Feng, Danielle, Schwarzschild, Michael A., McLean, Pamela J., Chen, Xiqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925445/ https://www.ncbi.nlm.nih.gov/pubmed/29433982 http://dx.doi.org/10.1016/j.ebiom.2018.01.035 |
Ejemplares similares
-
Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
por: Frey, Bryan, et al.
Publicado: (2020) -
Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation
por: Torres-Garcia, Laura, et al.
Publicado: (2022) -
Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
por: Cai, Waijiao, et al.
Publicado: (2022) -
Sulfurtransferase and thioredoxin specifically interact as demonstrated by bimolecular fluorescence complementation analysis and biochemical tests
por: Henne, Melina, et al.
Publicado: (2015) -
In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis
por: Ouzounoglou, Eleftherios, et al.
Publicado: (2014)